Zobrazeno 1 - 10
of 610
pro vyhledávání: '"Hepatitis C virus genotype"'
Autor:
Ching-Chu Lo, Wan-Long Chuang, Hsing-Tao Kuo, Wei-Ming Chen, Albert Qin, Chan-Yen Tsai, Yi-Wen Huang, Chi-Yi Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 1, Pp 55-61 (2024)
Aim: Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. Its biweekly dosing schema has demonstrated tolerability and clinical efficacy for treating chronic hepatitis in previous clinical studies. This trial evaluates the pharmacoki
Externí odkaz:
https://doaj.org/article/9850b955695541f483e388e3a8fae2e8
Autor:
Jyh-Jou Chen, Yen-Cheng Chiu, Pei-Lun Lee, Hung-Da Tung, Hung-Chih Chiu, Shih-Chieh Chien, Pin-Nan Cheng
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 11, Pp 2265-2272 (2022)
Background: Hepatitis C virus (HCV) genotype 6 mainly distributes in Southeast Asia and South China. Because of the low prevalence in developed countries, optimal treatment for HCV genotype 6 in real-world setting remains to be determined. We aimed t
Externí odkaz:
https://doaj.org/article/6853a350bfaf49a797de5617009dae45
Autor:
Showkat A Kadla, Nisar A Shah, Rupakshi Pathania, Bilal A Khan, Shahnaz A Mir, Asif I Shah, Shabir A Sheikh
Publikováno v:
Journal of Diabetology, Vol 11, Iss 2, Pp 101-108 (2020)
Introduction: Hepatitis C, in addition to liver disease, also causes extrahepatic manifestations in almost 35% of patients, resulting in a spectrum of autoimmune conditions. The prevalence of type 2 diabetes has been reported to be more in these pati
Externí odkaz:
https://doaj.org/article/7ec23f3a19ff4a35b03956c36ff6038e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Minosse C, Selleri M, Giombini E, Bartolini B, Capobianchi MR, Cerilli S, Loiacono L, Taibi C, D'Offizi G, McPhee F, Garbuglia AR
Publikováno v:
Infection and Drug Resistance, Vol Volume 11, Pp 2117-2127 (2018)
Claudia Minosse,1,* Marina Selleri,1,* Emanuela Giombini,1 Barbara Bartolini,1 Maria Rosaria Capobianchi,1 Stefano Cerilli,2 Laura Loiacono,2 Chiara Taibi,2 Gianpiero D’Offizi,2 Fiona McPhee,3 AnnaRosa Garbuglia1 1Department of Pre-clinical Researc
Externí odkaz:
https://doaj.org/article/93c14320136b41af8edeb2b823f70b54
Publikováno v:
Asian Journal of Transfusion Science, Vol 12, Iss 2, Pp 112-116 (2018)
Introduction: One of the most common blood-borne transfusion-transmitted diseases is hepatitis C. Patients with a history of multiple blood transfusions are significantly at a greater risk of infection by contaminated blood and blood products. Beta t
Externí odkaz:
https://doaj.org/article/c2e3320e55ea4cda9b7e9f5013d5cc1c
Publikováno v:
Терапевтический архив, Vol 89, Iss 12-2, Pp 197-203 (2017)
Aim. To identify predictors for the high efficiency of short-term interferon-containing antiviral therapy (AVT) using direct-acting antivirals (DAAs) in patients with chronic hepatitis C (CHC) virus (HCV) type 1 (CHC-1). Materials and methods. A tota
Externí odkaz:
https://doaj.org/article/8e398a1b429c4d82b589fbbdfc095e26
Autor:
Yone-Han Mah, Chen-Hua Liu, Chi-Ling Chen, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 115, Iss 11, Pp 953-960 (2016)
Clinical implications of IL28B gene in Taiwanese chronic hepatitis C (CHC) patients remain unknown. We thus investigated the prevalence and clinical implications of IL28B rs8099917 genotypes in CHC patients with different hepatitis C virus (HCV) geno
Externí odkaz:
https://doaj.org/article/e75c8f0d67a84ef68535192de9261f06
Publikováno v:
International Journal of TROPICAL DISEASE & Health. :1-12
Background: Treatment failure with direct-acting antiviral (DAA) therapy is associated with worsening of liver disease especially in cirrhotic patients. Moreover, data on retreatment of HCV genotype 4 patients (G4) with DAA failure are still very lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::693fbbca1cbfd617eb15c246b8c1f668
https://doi.org/10.9734/ijtdh/2021/v42i1330506
https://doi.org/10.9734/ijtdh/2021/v42i1330506
Autor:
Yi-Hao Yen, Jyh-Chwan Wang, Chao-Hung Hung, Sheng-Nan Lu, Jing-Houng Wang, Tsung-Hui Hu, Kwong-Ming Kee, Chang-Chun Hsiao, Chuan-Mo Lee
Publikováno v:
Journal of the Formosan Medical Association, Vol 114, Iss 7, Pp 652-658 (2015)
Whether serum proteome changes can predict treatment response in chronic hepatitis C remains unclear. We investigated the association between serum proteome changes and virological responses in chronic hepatitis C virus genotype 1b (HCV-1b) patients
Externí odkaz:
https://doaj.org/article/fdb589a0dd7f42d48bb52d23e48948a2